Menu

N

NewLimit

Verified

Visit Website Connect with Founders

Developing epigenetic therapies to extend human healthspan by reprogramming aging cells Biotech Healthcare

About NewLimit

NewLimit builds in the biotech category and is tracked by 100Xfounder for operating momentum, talent growth, and market execution.

What they do: Developing epigenetic therapies to extend human healthspan by reprogramming aging cells Biotech Healthcare

Funding context: Founders Fund, $130M Series B in 2025

Recent milestones:

NewLimit appears in the 100Xfounder startup directory import feed.

Why it Matters

NewLimit matters because developing epigenetic therapies to extend human healthspan by reprogramming aging cells Biotech Healthcare

Funding Snapshot

Total Funding: $130.00MLast Round: Series B Founders Fund, $130M Series B in 2025All Rounds: 1

Series B | Founders Fund, $130M Series B in 2025

Hiring Roles

This company is actively hiring.

Open Roles

Meet the Founders

NewLimit Team

NewLimit Team

Founder & CEO

Tech Stack

AWSReactPythonPostgreSQL

Last updated: April 17, 2026

NewLimit intelligence brief

This profile combines core company context with linked founder, funding, and newsroom routes so readers can evaluate business momentum without switching across multiple tools. Use it as a baseline for comparing peers in the same industry and stage.

For deeper validation, pair this page with founder profile, company news coverage, and stage-based funding hubs to contextualize updates against wider market movement.

Related Companies

Alternatives in Biotech with comparable market signals.

RT

ROME Therapeutics

ROME Therapeutics Team

View Company Compare Alternatives

HF

Hoxton Farms Team

View Company Compare Alternatives

K

Kernel Team

View Company Compare Alternatives

S

Synchron Team

View Company Compare Alternatives

CL

Clear Labs Team

View Company Compare Alternatives

BL

BioAge Labs Team

View Company Compare Alternatives

K

Karius Team

View Company Compare Alternatives

CT

CAMP4 Therapeutics

CAMP4 Therapeutics Team

View Company Compare Alternatives

Discover Now

Newsroom and topic pages connected to NewLimit.

Company News Hub Topic Hubs Funding News

No company-specific newsroom stories available yet.

Contextual Research Links

Jump to country, industry, stage, startup taxonomy, and newsroom routes tied to this company.

Company profile→Company news hub→Founder profile→United States startup directory→United States startup news→Startups in United States→Biotech hub→Biotech startup list→Series B startups→Series B startup list→

Want to get featured on 100Xfounder?

Want your company featured with founder details and funding visibility? Start here.

Contact Editorial Get Featured

FAQs About NewLimit

Common questions people ask about this profile.

What is NewLimit?

Developing epigenetic therapies to extend human healthspan by reprogramming aging cells Biotech Healthcare

Who founded NewLimit?

NewLimit is associated with NewLimit Team on 100Xfounder.

Where is NewLimit located?

NewLimit is listed in San Francisco Bay Area, California, USA.

What stage is NewLimit in?

NewLimit is currently mapped to Series B. Funding context: Founders Fund, $130M Series B in 2025

What is the latest funding round of NewLimit?

NewLimit's latest tracked round is Series B Founders Fund, $130M Series B in 2025. Total tracked rounds: 1.

Is NewLimit hiring now?

NewLimit hiring status: Open Roles.

What technologies does NewLimit use?

NewLimit is associated with AWS, React, Python, and PostgreSQL.

Is NewLimit verified on 100Xfounder?

Yes. NewLimit is currently marked verified on 100Xfounder as of April 17, 2026.

How can users connect with NewLimit founders?

Users can open founder profiles, use listed company links, and track signal updates directly from the 100Xfounder directory.